The study of 99mTc-radiolabeled peptide for breast cancer imaging
Phase 2
- Conditions
- C50.91Breast cancer.Malignant neoplasm of breast of unspecified site, female
- Registration Number
- IRCT20141006019423N3
- Lead Sponsor
- Mazandaran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 250
Inclusion Criteria
Female
breast cancer
Without biopsy history
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Radiotracer uptake by breast cancer. Timepoint: Imaging of the breast at 1,2,3 and 4 hours after the administration of the radiolabeled peptide. Method of measurement: Imaging.;Distribution of radiolabeled peptide in other tissues. Timepoint: Imaging at 1,2,3 and 4 hours after the administration of the radiolabeled peptide. Method of measurement: Imaging.
- Secondary Outcome Measures
Name Time Method